Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...

One dose of the Jynneos vaccine was 58% effective against mpox infection overall and 84% in people without HIV, but only 35% ...

Study findings provide a new gene pathway for potential treatment of the virus affecting millions. Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor ...

and developed genetic profiles of T cells, or white blood cells that are crucial to immune response and retain either active or inactive HIV. The researchers said their genetic analysis of the dormant ...

Her research focuses on how the immune system identifies invading pathogens. She has broken ground, the fund said, in how scientists understand T-cell recognition and immunization strategies for HIV.

Immunocore’s big swing for a functional HIV cure has cleared its first hurdle. No serious adverse events were tied to the British biotech’s bispecific T-cell engager in a phase 1/2 trial ...

This research on a T-cell–targeting vaccine in HIV has implications for future study design to incorporate consideration of ...

A year later, his plasma viral load, HIV RNA and DNA in peripheral blood cells and HIV-specific CD4 and CD8 T-cell responses were undetectable and his HIV antibody levels were low, so he stopped ...

Medically reviewed by Anju Goel, MD HIV and AIDS are related, but they are not the same thing. HIV (human immunodeficiency virus) is a sexually transmitted virus that causes illness by gradually ...

She has broken ground, the fund said, in how scientists understand T-cell recognition and immunization strategies for HIV. T cells are white blood cells that help fight off diseases. North Haven ...

NRTIs force the HIV virus to use faulty versions of building blocks so infected cells can't make more HIV. These are also called "non-nukes." NNRTIs bind to a specific protein, preventing the HIV ...